Redwood Shores, CA -- May 23, 2017 -- Reltio, the enterprise data-driven applications and modern data management Platform as a Service (PaaS) company, today announced that PM360, the premier information resource for marketing decision makers in the pharmaceutical and medical device sectors, named its CMO, Ramon Chen as one of their 2017 PM360 ELITE 100. Ramon Chen's honor follows Reltio CEO Manish Sood's recognition in 2015.
Now in its third year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today.
Ramon Chen is responsible for worldwide marketing and product management at Reltio. Prior to Reltio, he was VP of Product Marketing for Commercial, which encompassed Veeva CRM, Veeva Approved Email, Veeva Vault and Veeva Network at Veeva Systems.
Reltio provides Reltio Cloud, the only multitenant PaaS that enables organizations to build data-driven applications with reliable master data management (MDM), relevant big data insights, and intelligent recommended actions.
The PM360 ELITE Awards were established in 2015 to recognize individuals who have made a significant impact to the healthcare industry throughout their careers. More than 500 submissions were received and nominees were evaluated based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 18 categories, including Creative Directors, Data Miners, Digital Crusaders, Disrupters, Drug Researchers and Developers, Entrepreneurs, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.
Ramon Chen and the rest of the winners will be honored at a celebratory event on July 11th in New York City at the rooftop bar 230 FIFTH. Tickets are available for purchase at www.pm360online.com/elitetickets.
PM360 also selects one person as the “Uber ELITE,” or the individual among the nominees who best personifies the criteria of a PM360 ELITE. This year that honor goes to Nina Tandon, PhD, MBA CEO and Co-founder of EpiBone, Inc. Dr. Tandon co-founded the world’s first bone reconstruction facility that uses patients’ own stem cells to grow new bones. Dr. Tandon also co-authored, “Super Cells: Building with Biology,” which explores the new frontier of biotech. Additionally, she has been named by CNN as one of the “7 Tech Superheroes to Watch,” is a Ted Fellow, and has won a number of awards including The World Economic Forum Technology Pioneer Award.
The winners were profiled in PM360’s May 2017 issue. You can read all the profiles online at https://www.pm360online.com/the-2017-pm360-elite-100.
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.